Dr Laurence Steinfeld, MD | |
1850 N Columbia St, Milledgeville, GA 31061-2385 | |
(478) 453-4101 | |
Not Available |
Full Name | Dr Laurence Steinfeld |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 35 Years |
Location | 1850 N Columbia St, Milledgeville, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952341760 | NPI | - | NPPES |
00604304C | Medicaid | GA | |
034253 | Other | GA | STATE LICENSE # |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 034253 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Navicent Health Baldwin | Milledgeville, GA | Hospital |
Washington County Regional Medical Center | Sandersville, GA | Hospital |
Jasper Memorial Hospital | Monticello, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Oconee Radiology Associates | 1951299387 | 3 |
News Archive
Young coronary artery disease patients have a higher prevalence of hostility than older patients with the disease, researchers explain in the current issue of Mayo Clinic Proceedings. The authors say reducing hostility in these patients should be part of a rehabilitation program.
Biomedical scientist Kimberly L. Koss, PhD, is fighting an extremely aggressive and difficult-to-treat form of breast cancer.
French scientists say that anorexia is comparable to the drug Ecstasy as both appear to activate some of the same brain pathways
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of Allegra-D® (Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-release) 60mg/120mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.
› Verified 5 days ago
Entity Name | Oconee Radiology Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912074469 PECOS PAC ID: 1951299387 Enrollment ID: O20040308001031 |
News Archive
Young coronary artery disease patients have a higher prevalence of hostility than older patients with the disease, researchers explain in the current issue of Mayo Clinic Proceedings. The authors say reducing hostility in these patients should be part of a rehabilitation program.
Biomedical scientist Kimberly L. Koss, PhD, is fighting an extremely aggressive and difficult-to-treat form of breast cancer.
French scientists say that anorexia is comparable to the drug Ecstasy as both appear to activate some of the same brain pathways
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of Allegra-D® (Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-release) 60mg/120mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.
› Verified 5 days ago
Entity Name | Open Mri Of Milledgeville Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346255080 PECOS PAC ID: 3971538182 Enrollment ID: O20071022000409 |
News Archive
Young coronary artery disease patients have a higher prevalence of hostility than older patients with the disease, researchers explain in the current issue of Mayo Clinic Proceedings. The authors say reducing hostility in these patients should be part of a rehabilitation program.
Biomedical scientist Kimberly L. Koss, PhD, is fighting an extremely aggressive and difficult-to-treat form of breast cancer.
French scientists say that anorexia is comparable to the drug Ecstasy as both appear to activate some of the same brain pathways
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of Allegra-D® (Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-release) 60mg/120mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.
› Verified 5 days ago
Entity Name | Regional Open Mri, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528128790 PECOS PAC ID: 5092796318 Enrollment ID: O20160411000875 |
News Archive
Young coronary artery disease patients have a higher prevalence of hostility than older patients with the disease, researchers explain in the current issue of Mayo Clinic Proceedings. The authors say reducing hostility in these patients should be part of a rehabilitation program.
Biomedical scientist Kimberly L. Koss, PhD, is fighting an extremely aggressive and difficult-to-treat form of breast cancer.
French scientists say that anorexia is comparable to the drug Ecstasy as both appear to activate some of the same brain pathways
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of Allegra-D® (Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-release) 60mg/120mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Laurence Steinfeld, MD 116 Intracoastal Pointe Dr, Suite 300, Jupiter, FL 33477-5024 Ph: (561) 744-9122 | Dr Laurence Steinfeld, MD 1850 N Columbia St, Milledgeville, GA 31061-2385 Ph: (478) 453-4101 |
News Archive
Young coronary artery disease patients have a higher prevalence of hostility than older patients with the disease, researchers explain in the current issue of Mayo Clinic Proceedings. The authors say reducing hostility in these patients should be part of a rehabilitation program.
Biomedical scientist Kimberly L. Koss, PhD, is fighting an extremely aggressive and difficult-to-treat form of breast cancer.
French scientists say that anorexia is comparable to the drug Ecstasy as both appear to activate some of the same brain pathways
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of Allegra-D® (Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-release) 60mg/120mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.
› Verified 5 days ago
Dr. William A Willoughby, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 821 N Cobb St, Milledgeville, GA 31061 Phone: 478-452-0524 Fax: 478-452-0525 | |
Dr. Harvey L Simpson Iii, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 821 N Cobb St, Suite 100, Milledgeville, GA 31061 Phone: 478-454-3805 Fax: 478-454-3975 | |
Dr. Frederick Steven Falchook, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1850 N Columbia St, Milledgeville, GA 31061 Phone: 478-453-4101 |